Business Context and Reporting Period
This Form 8-K Current Report was filed by Pacific Biosciences of California, Inc. on December 7, 2023. The filing addresses a corporate governance event involving the Board of Directors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to a disclosure regarding personnel changes and does not contain financial performance data.
Material Changes
On December 7, 2023, David Botstein resigned from the Board of Directors, effective immediately. The Company stated it is not aware of any disagreement between Mr. Botstein and the Company regarding operations, policies, or practices that resulted in his resignation.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies beyond the immediate departure of the director.
Investor Verification Checklist
- Confirm the effective date of David Botstein's resignation (December 7, 2023).
- Verify the Company's statement that no disagreement existed regarding the resignation.
- Check for subsequent filings regarding the appointment of a replacement director.